Paid Clinical Trials for Endometrial Neoplasms

Showing all 6 results

A Study of LY4175408 in Participants With Advanced Cancer

in Carcinoma, Non-Small-Cell Lung, Triple Negative Breast Cancer, Neoplasm Metastasis, Endometrial Neoplasms, Small Cell Lung Carcinoma

Other

California

Deadline:

07/01/2030

A Study of Disitamab Vedotin in Previously Treated Solid Tumors That Express HER2

by CTG

in Carcinoma, Non-Small-Cell Lung, Ovarian Neoplasms, Head and Neck Neoplasms, Endometrial Neoplasms

Other

Arizona

Deadline:

05/31/2028

Study of Pembrolizumab (MK-3475) Versus Chemotherapy in Mismatch Repair Deficient (dMMR) Advanced or Recurrent Endometrial Carcinoma (MK-3475-C93/KEYNOTE-C93/GOG-3064/ENGOT-en15)

by CTG

in Endometrial Neoplasms

Other

Arizona

Deadline:

05/27/2027

Durvalumab With or Without Olaparib as Maintenance Therapy After First-Line Treatment of Advanced and Recurrent Endometrial Cancer

by CTG

in Endometrial Neoplasms

Other

Arizona

Deadline:

04/01/2027

A Study of DM002 in Patients With Advanced Solid Tumors

by CTG

in Prostatic Neoplasms, Ovarian Neoplasms, Solid Carcinoma, Colorectal Neoplasms, Endometrial Neoplasms

Other

Texas

Deadline:

04/18/2028

Study of LY3537982 in Cancer Patients With a Specific Genetic Mutation (KRAS G12C)

by CTG

in Carcinoma, Non-Small-Cell Lung, Ovarian Neoplasms, Pancreatic Neoplasms, Colorectal Neoplasms, Endometrial Neoplasms

Other

Alabama

Deadline:

06/01/2026

A Study of LY4175408 in Participants With Advanced Cancer

A Study of Disitamab Vedotin in Previously Treated Solid Tumors That Express HER2

Study of Pembrolizumab (MK-3475) Versus Chemotherapy in Mismatch Repair Deficient (dMMR) Advanced or Recurrent Endometrial Carcinoma (MK-3475-C93/KEYNOTE-C93/GOG-3064/ENGOT-en15)

Durvalumab With or Without Olaparib as Maintenance Therapy After First-Line Treatment of Advanced and Recurrent Endometrial Cancer

A Study of DM002 in Patients With Advanced Solid Tumors

Study of LY3537982 in Cancer Patients With a Specific Genetic Mutation (KRAS G12C)

Follow us on social media:

Participants

Organizations

Products

About Us

Mobile Apps

Get new clinical trials sent to you?

Paid Clinical Trials for Endometrial Neoplasms

Filter Results:

A Study of LY4175408 in Participants With Advanced Cancer

A Study of Disitamab Vedotin in Previously Treated Solid Tumors That Express HER2

Study of Pembrolizumab (MK-3475) Versus Chemotherapy in Mismatch Repair Deficient (dMMR) Advanced or Recurrent Endometrial Carcinoma (MK-3475-C93/KEYNOTE-C93/GOG-3064/ENGOT-en15)

Durvalumab With or Without Olaparib as Maintenance Therapy After First-Line Treatment of Advanced and Recurrent Endometrial Cancer

A Study of DM002 in Patients With Advanced Solid Tumors

Study of LY3537982 in Cancer Patients With a Specific Genetic Mutation (KRAS G12C)

Follow us on social media:

Participants

Organizations

Products

About Us

Mobile Apps